UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 11-K
(Mark One)
x
|
ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the fiscal year ended December 31, 2003 | ||
OR | ||
o
|
TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number 000-12477
RETIREMENT AND SAVINGS PLAN FOR AMGEN
MANUFACTURING, LIMITED
State Road 31, Kilometer 24.6, Juncos, Puerto Rico 00777
(Full title of the plan)
AMGEN INC.
One Amgen Center Drive, Thousand Oaks, California | 91320-1799 | |
(Address of principal executive offices) | (Zip Code) |
The Retirement and Savings Plan for
Amgen Manufacturing, Limited
Financial Statements and
Supplemental Schedule
Years ended December 31, 2003 and 2002
Contents
1 | ||||||||
Audited Financial Statements |
||||||||
2 | ||||||||
3 | ||||||||
4 | ||||||||
Supplemental Schedule |
||||||||
8 | ||||||||
EXHIBIT 23 |
Report of Independent Registered Public Accounting Firm
Amgen Puerto Rico, Inc., as Named Fiduciary,
and the Plan Participants of The Retirement
and Savings Plan for Amgen Manufacturing, Limited
We have audited the accompanying statements of net assets available for benefits of The Retirement and Savings Plan for Amgen Manufacturing, Limited (the Plan) as of December 31, 2003 and 2002, and for the related statements of changes in net assets available for benefits for the years then ended. These financial statements are the responsibility of the Plans management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the net assets available for benefits of the Plan at December 31, 2003 and 2002, and the changes in its net assets available for benefits for the years then ended in conformity with U.S. generally accepted accounting principles.
Our audits were performed for the purpose of forming an opinion on the financial statements taken as a whole. The accompanying supplemental schedule of assets (held at end of year) as of December 31, 2003, is presented for purposes of additional analysis and is not a required part of the financial statements but is supplementary information required by the Department of Labors Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. This supplemental schedule is the responsibility of the Plans management. This supplemental schedule has been subjected to the auditing procedures applied in our audits of the financial statements and, in our opinion, is fairly stated in all material respects in relation to the financial statements taken as a whole.
/s/ ERNST & YOUNG LLP
June 3, 2004
Stamp No. 1967126
affixed to
original of
this report.
1
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Statements of Net Assets Available for Benefits
December 31, | ||||||||
2003 |
2002 |
|||||||
Assets |
||||||||
Investments at fair value |
$ | 31,971,387 | $ | 21,292,678 | ||||
Contributions receivable |
| 136,579 | ||||||
Net assets available for benefits |
$ | 31,971,387 | $ | 21,429,257 | ||||
See accompanying notes.
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Statements of Changes in Net Assets Available for Benefits
Years ended December 31, | ||||||||
2003 |
2002 |
|||||||
Additions to net assets: |
||||||||
Employee contributions |
$ | 3,404,996 | $ | 1,550,850 | ||||
Employer contributions |
2,909,214 | 1,683,078 | ||||||
Interest and dividend income |
278,468 | 220,940 | ||||||
Net realized/unrealized gain |
5,192,707 | | ||||||
Total additions |
11,785,385 | 3,454,868 | ||||||
Deductions from net assets: |
||||||||
Benefits paid |
1,243,255 | 629,254 | ||||||
Net realized/unrealized loss |
| 3,559,655 | ||||||
Total deductions |
1,243,255 | 4,188,909 | ||||||
Net increase/(decrease) |
10,542,130 | (734,041 | ) | |||||
Net assets available for benefits at beginning of year |
21,429,257 | 22,163,298 | ||||||
Net assets available for benefits at end of year |
$ | 31,971,387 | $ | 21,429,257 | ||||
See accompanying notes.
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements
December 31, 2003
1. | Description of the Plan |
The following description of The Retirement and Savings Plan for Amgen Manufacturing, Limited (the Plan) provides only general information. Participants should refer to the Plan document for a more complete description of the Plans provisions.
General
The Plan was established effective May 1, 1992 (amended and restated effective April 1, 1996) as a defined contribution plan covering substantially all domestic employees of Amgen Puerto Rico, Inc. On January 1, 2002, Amgen Manufacturing, Limited (the Company) assumed the responsibilities of the work force of Amgen Puerto Rico, Inc. The Plan, as amended, is intended to qualify under sections 1165(a) and (e) of the Puerto Rico Internal Revenue Code of 1994, as amended (the PR Code), sections 401(a) and 401(k) of the United States Internal Revenue Code of 1986 (the US Code) (see Note 4 Income Tax Status) and section 407(d)(3)(A) of the Employee Retirement Income Security Act of 1974 (ERISA). On January 1, 2002, the name of the Plan was changed from The Retirement and Savings Plan for Amgen Puerto Rico, Inc. to Amgen Manufacturing, Limited, which assumed the responsibilities of the work force of Amgen Puerto Rico, Inc.
Contributions
During 2003 and 2002, participants could elect to contribute up to 10% of their pretax annual compensation (up to a maximum contribution of $8,000). Participants may also contribute amounts representing distributions from other qualified defined benefit or defined contribution plans.
Each pay period, the Company makes a contribution of 100% of the first 5% of eligible compensation contributed by the employee (Matching contribution). In addition, the Company supplements the Matching contribution for all eligible employees, whether or not they have elected to make contributions to the Plan, with a contribution equal to 3% of each eligible employees compensation (Core contribution).
Participants select the funds in which their contributions are to be invested, electing among various investment alternatives. Participants may elect for their contributions to be invested in more than one fund; however, no more than 50% of the value of the participant account may be invested in the Amgen Inc. Stock Fund. Participants may transfer amounts among the investment options at any time, subject to certain Securities and Exchange Commission limitations.
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)
1. | Description of the Plan (continued) |
Vesting
Participants are immediately vested with respect to their individual contributions and earnings thereon. Participants become vested in their allocated Company Matching contributions and related earnings at a rate of 25% per year for each of their first four years of service completed.
The Companys Core contributions and related earnings become 100% vested upon completion of five years of service, with no partial vesting. Generally, employees must work a minimum of 1,000 hours within a Plan year to receive vesting for that year of service. Company contributions become fully vested upon attainment of normal retirement age, disability, or death.
Participant Accounts
Each participants account is credited with the participants contributions and an allocation of (a) Company contributions and (b) Plan earnings and losses. The benefit to which a participant is entitled is the benefit that can be provided from the participants account. Forfeited balances of terminated participants nonvested accounts during 2003 and 2002 were used to reduce future Company contributions.
Payment of Benefits
Upon termination of service due to death, disability (as defined by the Plan), retirement, or severance from employment, a participant may elect to receive an amount equal to the value of the participants vested account balance in either a lump-sum payment in cash and/or full shares of the Companys common stock. The number of shares of Company common stock to be paid is based on the quoted market value of such stock on the date the Plan is valued following employee notification.
Generally, participants may not make withdrawals of amounts from the Plan while a participant continues to be employed by the Company.
Participant Loans
Subject to the Companys approval, participants can generally obtain a loan from their account up to the lesser of an amount equal to 50% of the participants vested account balance or $50,000, less the highest balance of any outstanding loans within the previous twelve months. The loans bear interest at average borrowing rates of certain major banks (ranging from 7.42% to 12.66%) and are generally payable in installments over periods ranging from one to five years. Principal and interest payments are allocated to the participants account.
Plan Termination
Effective as of 12:00 a.m. on January 1, 2004, Amgen Puerto Rico, Inc. transferred all of the assets of the Plan to a new plan, also named The Retirement and Savings Plan for Amgen Manufacturing, Limited. The assets of the Plan were transferred within the same trustee and at the same fund balances as December 31, 2003. Immediately following the transfer, Amgen Puerto Rico, Inc. terminated the Plan.
5
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)
1. | Description of the Plan (continued) |
Trustee
Banco Santander acts as the Plans trustee.
2. | Summary of Significant Accounting Policies |
Basis of Accounting
The financial statements have been prepared on the accrual basis of accounting.
Investment Income and Losses
Dividend income is recognized on the ex-dividend date and interest income is recorded on an accrual basis. Unrealized gains and losses on investments are measured by the change in the difference between the fair value and cost of the securities held at the beginning and end of the period. Realized gains and losses from security transactions are recorded based on the weighted-average cost of securities sold.
Investment Valuation
Investments in mutual funds and Amgen Inc. common stock are valued at current market values determined through reference to public market information on the last business day of the Plan year. Participant loans are valued at their outstanding balances, which approximate fair value.
Use of Estimates
The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
3. | Investments |
The fair value of individual investments that represent 5% or more of the Plans net assets are as follows:
December 31, | ||||||||
2003 |
2002 |
|||||||
Amgen Inc. Common Stock |
$ | 13,724,229 | $ | 9,542,266 | ||||
Fidelity Magellan Fund |
4,268,512 | 2,693,672 | ||||||
Fidelity Spartan U.S. Equity Index |
2,247,324 | 1,592,417 | ||||||
Fidelity OTC Portfolio |
2,249,081 | 1,410,080 | ||||||
Fidelity Growth and Income Portfolio |
1,710,968 | 1,129,172 | ||||||
$ | 24,200,114 | $ | 16,367,607 | |||||
6
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)
3. | Investments (continued) |
During 2003 and 2002, the Plans investments (including gains and losses on investments bought and sold, as well as held during the year) appreciated/(depreciated) in value as follows:
Year ended December 31, | ||||||||
2003 |
2002 |
|||||||
Amgen Inc. Common Stock |
$ | 2,591,836 | $ | (1,469,185 | ) | |||
Mutual funds |
2,600,871 | (2,090,470 | ) | |||||
$ | 5,192,707 | $ | (3,559,655 | ) | ||||
4. | Income Tax Status |
In June 1997, the Company received a determination letter from the Puerto Rico Treasury Department, stating that the Plan is qualified, in form, under the PR Code and, therefore, the related trust forming a part of the Plan is exempt from taxation. Once qualified, the Plan is required to operate in conformity with the PR Code to maintain its qualification. The Company received a determination letter from the United States Internal Revenue Service (the IRS) dated April 25, 2000 stating that the Plan is qualified under the US Code. The Company believes the Plan was being operated in compliance with the applicable requirements of the PR Code and the US Code, except for the timely adoption of certain amendments. During 2002, the Plan did not adopt amendments to comply with the Economic Growth and Tax Relief Reconciliation Act of 2001 (the EGTRRA) within the period specified by the IRS. In order to correct this event of noncompliance, the Plan sponsor is in the process of preparing and submitting an application under the Voluntary Compliance Program (the VCP) of the Employee Plans Compliance Resolution System in accordance with the procedures set forth in Revenue Procedure 2002-44. The Plan sponsor will take such corrective action as may be required in connection with the VCP filing to maintain the Plans qualified tax-exempt status, including adoption of a good faith EGTRRA amendment within the time period specified in the compliance statement issued by the IRS.
5. | Services Provided by the Company |
The Company provides certain administrative and record keeping services for the Plan at no cost to the Plan participants. In addition, the Company has paid the trustee fees and other related costs on behalf of the Plan.
7
Supplemental Schedule
The Retirement and Savings Plan for Amgen Manufacturing, Limited
EIN: 98-0210484 Plan: 35322
Schedule H, Line 4i Schedule of Assets (Held at End of Year)
December 31, 2003
Description of | Current | |||||
Identity of Issue |
Investment |
Value |
||||
Amgen Inc.*
|
Common stock 222,086 shares | $ | 13,724,229 | |||
Fidelity Magellan Fund*
|
Mutual fund 43,672 shares | 4,268,512 | ||||
Fidelity Growth and Income Portfolio*
|
Mutual fund 48,020 shares | 1,710,968 | ||||
Fidelity Retirement Money Market Portfolio*
|
Money market portfolio | 1,384,005 | ||||
Fidelity Overseas Fund*
|
Mutual fund 29,809 shares | 936,891 | ||||
Fidelity Spartan U.S. Equity Index*
|
Mutual fund 57,024 shares | 2,247,324 | ||||
Fidelity Short-Term Bond*
|
Mutual fund 132,688 shares | 1,199,504 | ||||
Fidelity OTC Portfolio*
|
Mutual fund 69,266 shares | 2,249,081 | ||||
Fidelity Asset Manager*
|
Mutual fund 21,960 shares | 346,089 | ||||
Fidelity Asset Manager: Growth*
|
Mutual fund 43,422 shares | 620,065 | ||||
Fidelity Asset Manager: Income*
|
Mutual fund 29,724 shares | 361,148 | ||||
Fidelity U.S. Bond Index Portfolio*
|
Mutual fund 59,062 shares | 660,906 | ||||
Fidelity Contrafund*
|
Mutual fund 17,654 shares | 871,247 | ||||
Participant loans*
|
Interest rates from 7.42 % to 12.66% | 1,391,418 | ||||
$ | 31,971,387 | |||||
*Party-in-interest
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
Retirement and Savings Plan for Amgen | ||||||
Manufacturing, Limited | ||||||
(Name of Plan) | ||||||
Date:
|
6/28/04 | By: | /s/ Richard D. Nanula | |||
Richard D. Nanula | ||||||
Chief Financial Officer | ||||||
Amgen Manufacturing, Limited |
9
The Retirement and Savings Plan for Amgen Manufacturing, Limited
Index to Exhibit
Consent of Ernst & Young LLP, |
||
Independent Registered Public Accounting Firm
|
Exhibit 23 |